Volutrip is a single daily tablet containing three HIV medicines — tenofovir, lamivudine and dolutegravir. It is South Africa’s standard first-line HIV treatment, known as TLD. Taken every day it suppresses the virus to undetectable levels, which means it cannot be passed on sexually.

What is Volutrip?

The South African Medicine Price Registry lists Volutrip as a Schedule 4 tablet containing:

IngredientStrengthClass
Tenofovir disoproxil fumarate300 mgNRTI
Lamivudine300 mgNRTI
Dolutegravir50 mgIntegrase inhibitor

This combination is TLD, the first-line antiretroviral regimen in South Africa’s national HIV programme.

Several brands contain exactly the same three medicines — Volutrip, Telatri, Acriptega and others. If your clinic or pharmacy gives you a different brand from last time, nothing about your treatment has changed. The tablets may differ in colour, size or shape, and the box will look unfamiliar, but the medicine is identical.

This is worth stating plainly, because it causes real anxiety. Brand switching happens as supply contracts change, and people sometimes stop their tablets thinking they were given the wrong thing. Check the three ingredient names on the box — tenofovir, lamivudine, dolutegravir — and if they match, keep taking it.

Three medicines, three points of attack. HIV mutates rapidly, and a single medicine would be defeated within weeks. Three acting at different stages make escape extremely unlikely — provided all three are present continuously.

Tenofovir and lamivudine are NRTIs — faulty building blocks that halt the chain as HIV converts its RNA into DNA. Dolutegravir is an integrase inhibitor, blocking the enzyme HIV uses to stitch its DNA into the human genome. It is potent and has a high barrier to resistance, which is why TLD replaced the older efavirenz regimens.

“Undetectable” means untransmittable. With consistent treatment, viral load usually falls below detection within three to six months. The virus is not gone — it persists in resting cells and returns if treatment stops — but an undetectable viral load means HIV cannot be transmitted sexually. This is established beyond reasonable doubt and known as U=U.

What is Volutrip commonly used for?

Taking it every day, at roughly the same time, is the whole of the treatment. Missed doses let the virus replicate, and replication is when resistance develops — which can force a switch to more complex second-line treatment. Adherence is not a moral matter; it is the mechanism by which the medicine works.

What helps in practice: a phone alarm, tying the dose to a fixed routine, a pill box, and collecting repeats before you run out. Running out is one of the commonest causes of missed doses and is entirely preventable.

If you miss a dose, take it when you remember unless the next is nearly due — then skip it and carry on. Never double up. If you have missed several days, take today’s dose and contact your clinic.

HIV treatment is lifelong. Stopping lets the virus rebound within weeks and the immune system decline again. Feeling completely well is what successful treatment looks like, not a sign it is no longer needed.

How Volutrip fits into this medicine category

ClassExamplesAction
NRTIsTenofovir, lamivudine (in Volutrip), abacavir, emtricitabineFaulty building blocks; halt DNA copying
Integrase inhibitorsDolutegravir (in Volutrip)Block insertion into human DNA
NNRTIsEfavirenz, nevirapineBlock the same enzyme differently
Protease inhibitorsLopinavir, atazanavirBlock assembly of new virus
Fixed-dose combinationsVolutrip, Telatri, AcriptegaThree medicines, one tablet

One tablet a day is a genuine achievement. It replaced regimens of many tablets several times daily, and the improvement in adherence — and therefore survival — has been substantial.

See the HIV and antiviral medicines hub.

What to check before using Volutrip

Tell your doctor, clinic or pharmacist if you:

Practical points:

Possible cautions and when to ask a pharmacist or doctor

Common effects, mostly early and settling within weeks: headache, nausea, diarrhoea, tiredness, difficulty sleeping and vivid dreams. Dolutegravir causes weight gain in some people, which is well recognised — mention it rather than stopping.

Get emergency help for:

Seek prompt advice for:

Contact your clinic if:

Related medicine guides

Frequently asked questions

What is Volutrip used for? Treating HIV. It contains tenofovir, lamivudine and dolutegravir — the combination known as TLD, South Africa’s first-line HIV treatment.

Is Volutrip the same as Telatri or Acriptega? Yes in content. All contain the same three medicines at the same strengths, from different manufacturers.

My tablets look different this month. Should I stop? No. Check the three ingredient names on the box — tenofovir, lamivudine, dolutegravir. If they match, keep taking it. Brand changes happen as supply contracts change.

Does it cure HIV? No. It suppresses the virus so effectively that it becomes undetectable and the immune system recovers, but the virus persists and returns if treatment stops.

Can I pass HIV on while taking it? Once your viral load is undetectable and stays so, HIV cannot be transmitted sexually. This is U=U — Undetectable equals Untransmittable.

What if I miss a dose? Take it when you remember unless the next is nearly due, then skip it. Never double up. If you have missed several days, contact your clinic.

Can I take antacids or calcium with it? Not at the same time. They bind dolutegravir and reduce it substantially. Separate by at least 2 hours before or 6 hours after.

What if I need TB treatment? Tell your clinic. Rifampicin lowers dolutegravir significantly and the dose must be adjusted. Do not manage this yourself.

Can I stop when I feel well? No. Treatment is lifelong, and feeling well is what success looks like. Stopping lets the virus rebound within weeks.